# Islatravir Clinical Development for HIV and HBV

**ID:** TRT-012
**Year:** 2024
**Source:** PubMed
**Link:** [https://pubmed.ncbi.nlm.nih.gov/38235744/](https://pubmed.ncbi.nlm.nih.gov/38235744/)

---

## Abstract

Evaluation of islatravir's clinical development history, dose optimization, and dual HIV/HBV potential.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
